180 related articles for article (PubMed ID: 38151291)
1. Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis.
Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
[TBL] [Abstract][Full Text] [Related]
3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
4. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
7. A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma.
Li C; Yuan Q; Xu G; Yang Q; Hou J; Zheng L; Wu G
World J Surg Oncol; 2022 Apr; 20(1):129. PubMed ID: 35459137
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X
BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864
[TBL] [Abstract][Full Text] [Related]
9. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
10. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
Liu Y; Yin Z; Wang Y; Chen H
Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
[TBL] [Abstract][Full Text] [Related]
11. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
13. TTN mutations predict a poor prognosis in patients with thyroid cancer.
Han X; Chen J; Wang J; Xu J; Liu Y
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
[TBL] [Abstract][Full Text] [Related]
14. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
[TBL] [Abstract][Full Text] [Related]
15. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
[TBL] [Abstract][Full Text] [Related]
16. Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma.
Tang M; Luo W; Zhou Y; Zhang Z; Jiang Z
Transl Oncol; 2024 Feb; 40():101873. PubMed ID: 38141377
[TBL] [Abstract][Full Text] [Related]
17. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
Fei H; Han X; Wang Y; Li S
Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Prognosis of Thyroid Cancer by Immune-related Genes.
Li J; Li Z; Zhao P
Am J Clin Oncol; 2024 Jan; 47(1):1-10. PubMed ID: 37779238
[TBL] [Abstract][Full Text] [Related]
19. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
20. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]